Virtual Medicinal Product (VMP) - Insulin isophane biphasic human 25/75 100units/ml suspension for injection 5ml vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Insulin isophane biphasic human 25/75 100units/ml suspension for injection 5ml vials Start Date 24-06-2004 End Date
Previous Name Previous Name Insulin isophane biphasic human 25/75 100units/ml injection 5ml vials Start Date 17-12-2002 End Date 23-06-2004
Abbreviated Name Abbreviated Name Insulin isophane biphas hum 25/75 100units/ml inj 5ml vials Start Date 01-05-2009
Previous Abbreviated Name Insulin isophane biphas hum 25/75 100units/ml inj 5ml vl Previous Start Date 06-10-2005 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Subcutaneous
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.subcutaneous
Non-availability Indicator
Actual Products not Available
Name Basis
BAN - British Approved Name

Codes

ATC Code
A10AD01
BNF Start Date End Date
Current BNF 06010102 Start Date 04-04-2022 End Date
Previous BNF 06010102 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3470411000001100 17-12-2002

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Insulin isophane human Based on Base Substance Insulin human 75 unit 1 ml
Insulin soluble human Based on Base Substance Insulin human 25 unit 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial